Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Designer molecules promise bone repair breakthrough

This article was originally published in Clinica

Executive Summary

Newly designed molecules that mimic the nanostructure of bone could lead to a breakthrough in bone repair, a US study suggests. The "designer" molecules hold promise for the development of bone-like material for use in fractures or even for treating bone cancer, say researchers from Northwestern University in Evanston, Illinois, who describe the molecules in Science (November 23). The molecules may also have application in the regeneration of other tissues and organs, they add.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel